289 related articles for article (PubMed ID: 19481932)
1. Discovery of spirocyclic secondary amine-derived tertiary ureas as highly potent, selective and bioavailable soluble epoxide hydrolase inhibitors.
Shen HC; Ding FX; Wang S; Xu S; Chen HS; Tong X; Tong V; Mitra K; Kumar S; Zhang X; Chen Y; Zhou G; Pai LY; Alonso-Galicia M; Chen X; Zhang B; Tata JR; Berger JP; Colletti SL
Bioorg Med Chem Lett; 2009 Jul; 19(13):3398-404. PubMed ID: 19481932
[TBL] [Abstract][Full Text] [Related]
2. Discovery of 3,3-disubstituted piperidine-derived trisubstituted ureas as highly potent soluble epoxide hydrolase inhibitors.
Shen HC; Ding FX; Deng Q; Xu S; Chen HS; Tong X; Tong V; Zhang X; Chen Y; Zhou G; Pai LY; Alonso-Galicia M; Zhang B; Roy S; Tata JR; Berger JP; Colletti SL
Bioorg Med Chem Lett; 2009 Sep; 19(18):5314-20. PubMed ID: 19682899
[TBL] [Abstract][Full Text] [Related]
3. Discovery of a highly potent, selective, and bioavailable soluble epoxide hydrolase inhibitor with excellent ex vivo target engagement.
Shen HC; Ding FX; Wang S; Deng Q; Zhang X; Chen Y; Zhou G; Xu S; Chen HS; Tong X; Tong V; Mitra K; Kumar S; Tsai C; Stevenson AS; Pai LY; Alonso-Galicia M; Chen X; Soisson SM; Roy S; Zhang B; Tata JR; Berger JP; Colletti SL
J Med Chem; 2009 Aug; 52(16):5009-12. PubMed ID: 19645482
[TBL] [Abstract][Full Text] [Related]
4. Optimization of piperidyl-ureas as inhibitors of soluble epoxide hydrolase.
Eldrup AB; Soleymanzadeh F; Farrow NA; Kukulka A; De Lombaert S
Bioorg Med Chem Lett; 2010 Jan; 20(2):571-5. PubMed ID: 19969453
[TBL] [Abstract][Full Text] [Related]
5. Discovery of 2,8-diazaspiro[4.5]decane-based trisubstituted urea derivatives as highly potent soluble epoxide hydrolase inhibitors and orally active drug candidates for treating hypertension.
Kato Y; Fuchi N; Saburi H; Nishimura Y; Watanabe A; Yagi M; Nakadera Y; Higashi E; Yamada M; Aoki T
Bioorg Med Chem Lett; 2013 Nov; 23(21):5975-9. PubMed ID: 24035338
[TBL] [Abstract][Full Text] [Related]
6. Exploration of secondary and tertiary pharmacophores in unsymmetrical N,N'-diaryl urea inhibitors of soluble epoxide hydrolase.
Anandan SK; Gless RD
Bioorg Med Chem Lett; 2010 May; 20(9):2740-4. PubMed ID: 20363133
[TBL] [Abstract][Full Text] [Related]
7. A strategy of employing aminoheterocycles as amide mimics to identify novel, potent and bioavailable soluble epoxide hydrolase inhibitors.
Shen HC; Ding FX; Deng Q; Xu S; Tong X; Zhang X; Chen Y; Zhou G; Pai LY; Alonso-Galicia M; Roy S; Zhang B; Tata JR; Berger JP; Colletti SL
Bioorg Med Chem Lett; 2009 Oct; 19(19):5716-21. PubMed ID: 19700315
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and SAR of conformationally restricted inhibitors of soluble epoxide hydrolase.
Jones PD; Tsai HJ; Do ZN; Morisseau C; Hammock BD
Bioorg Med Chem Lett; 2006 Oct; 16(19):5212-6. PubMed ID: 16870439
[TBL] [Abstract][Full Text] [Related]
9. Discovery of 1-oxa-4,9-diazaspiro[5.5]undecane-based trisubstituted urea derivatives as highly potent soluble epoxide hydrolase inhibitors and orally active drug candidates for treating of chronic kidney diseases.
Kato Y; Fuchi N; Nishimura Y; Watanabe A; Yagi M; Nakadera Y; Higashi E; Yamada M; Aoki T; Kigoshi H
Bioorg Med Chem Lett; 2014 Jan; 24(2):565-70. PubMed ID: 24373724
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and biological activity of 1,3-disubstituted ureas as potent inhibitors of the soluble epoxide hydrolase of increased water solubility.
Kim IH; Morisseau C; Watanabe T; Hammock BD
J Med Chem; 2004 Apr; 47(8):2110-22. PubMed ID: 15056008
[TBL] [Abstract][Full Text] [Related]
11. Peptidyl-urea based inhibitors of soluble epoxide hydrolases.
Morisseau C; Newman JW; Tsai HJ; Baecker PA; Hammock BD
Bioorg Med Chem Lett; 2006 Oct; 16(20):5439-44. PubMed ID: 16908134
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of substituted nicotinamides as inhibitors of soluble epoxide hydrolase.
Taylor SJ; Soleymanzadeh F; Eldrup AB; Farrow NA; Muegge I; Kukulka A; Kabcenell AK; De Lombaert S
Bioorg Med Chem Lett; 2009 Oct; 19(20):5864-8. PubMed ID: 19758802
[TBL] [Abstract][Full Text] [Related]
13. Identification of potent, noncovalent fatty acid amide hydrolase (FAAH) inhibitors.
Gustin DJ; Ma Z; Min X; Li Y; Hedberg C; Guimaraes C; Porter AC; Lindstrom M; Lester-Zeiner D; Xu G; Carlson TJ; Xiao S; Meleza C; Connors R; Wang Z; Kayser F
Bioorg Med Chem Lett; 2011 Apr; 21(8):2492-6. PubMed ID: 21392988
[TBL] [Abstract][Full Text] [Related]
14. Rapid synthesis of an array of trisubstituted urea-based soluble epoxide hydrolase inhibitors facilitated by a novel solid-phase method.
Kowalski JA; Swinamer AD; Muegge I; Eldrup AB; Kukulka A; Cywin CL; De Lombaert S
Bioorg Med Chem Lett; 2010 Jun; 20(12):3703-7. PubMed ID: 20472432
[TBL] [Abstract][Full Text] [Related]
15. Discovery of polar spirocyclic orally bioavailable urea inhibitors of soluble epoxide hydrolase.
Lukin A; Kramer J; Hartmann M; Weizel L; Hernandez-Olmos V; Falahati K; Burghardt I; Kalinchenkova N; Bagnyukova D; Zhurilo N; Rautio J; Forsberg M; Ihalainen J; Auriola S; Leppänen J; Konstantinov I; Pogoryelov D; Proschak E; Dar'in D; Krasavin M
Bioorg Chem; 2018 Oct; 80():655-667. PubMed ID: 30059891
[TBL] [Abstract][Full Text] [Related]
16. Oral delivery of 1,3-dicyclohexylurea nanosuspension enhances exposure and lowers blood pressure in hypertensive rats.
Ghosh S; Chiang PC; Wahlstrom JL; Fujiwara H; Selbo JG; Roberds SL
Basic Clin Pharmacol Toxicol; 2008 May; 102(5):453-8. PubMed ID: 18312493
[TBL] [Abstract][Full Text] [Related]
17. Potent urea and carbamate inhibitors of soluble epoxide hydrolases.
Morisseau C; Goodrow MH; Dowdy D; Zheng J; Greene JF; Sanborn JR; Hammock BD
Proc Natl Acad Sci U S A; 1999 Aug; 96(16):8849-54. PubMed ID: 10430859
[TBL] [Abstract][Full Text] [Related]
18. Structure-based optimization of arylamides as inhibitors of soluble epoxide hydrolase.
Eldrup AB; Soleymanzadeh F; Taylor SJ; Muegge I; Farrow NA; Joseph D; McKellop K; Man CC; Kukulka A; De Lombaert S
J Med Chem; 2009 Oct; 52(19):5880-95. PubMed ID: 19746975
[TBL] [Abstract][Full Text] [Related]
19. 1-(1-acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea (AR9281) as a potent, selective, and orally available soluble epoxide hydrolase inhibitor with efficacy in rodent models of hypertension and dysglycemia.
Anandan SK; Webb HK; Chen D; Wang YX; Aavula BR; Cases S; Cheng Y; Do ZN; Mehra U; Tran V; Vincelette J; Waszczuk J; White K; Wong KR; Zhang LN; Jones PD; Hammock BD; Patel DV; Whitcomb R; MacIntyre DE; Sabry J; Gless R
Bioorg Med Chem Lett; 2011 Feb; 21(3):983-8. PubMed ID: 21211973
[TBL] [Abstract][Full Text] [Related]
20. Three-dimensional rational approach to the discovery of potent substituted cyclopropyl urea soluble epoxide hydrolase inhibitors.
Takai K; Chiyo N; Nakajima T; Nariai T; Ishikawa C; Nakatani S; Ikeno A; Yamamoto S; Sone T
Bioorg Med Chem Lett; 2015 Apr; 25(8):1705-1708. PubMed ID: 25800114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
